Source: Annual Congress 2001 - Pulmonary hypertension: effect of iloprost
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Baumgartner, H. Leuchte, T. Kolbe, M. Schwaiblmair, J. Behr (Munich, Germany). Acute effects, 1-year, and 2-year follow up of iloprost-aerosol therapy in severe primary pulmonary hypertension. Eur Respir J 2001; 16: Suppl. 31, 2161

Member's Comments

No comment yet.

Related content which might interest you: Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 The controlled study of a 6-month course of acute pulmonary embolism in patients with syncope at admission Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Effect of exercise and respiratory training on time to clinical worsening and survival in patients with severe chronic pulmonary hypertension Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Impact of long-term oxygen therapy on diaphragm function and pulmonary-cardiac hemodynamics in patients with COPD with hypoxemia (3-year assessment) Source: International Congress 2019 – Lung function and respiratory muscle testing Year: 2019 Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Source: Eur Respir J 2015; 45: 1293-1302 Year: 2015 The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study Source: Eur Respir J 2006; 28: 138-143 Year: 2006 Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Oral anticoagulation therapy in pediatric pulmonary hypertension: A 10-year registry survival analysis Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Effects of the home-realized 6 months follow-up study individually designed exercise programme on patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 556s Year: 2006 Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Predictors of success and failure in pulmonary rehabilitation Source: Eur Respir J 2006; 27: 788-794 Year: 2006 3-month follow up in patients with hemodynamic stable acute pulmonary embolism with syncope as the presenting symptom Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Efficacy of epoprostenol treatment for pulmonary hypertension: hemodynamic and clinical improvement during the initial 8-month period Source: Eur Respir J 2001; 18: Suppl. 33, 325s Year: 2001 Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011